AskBio CEO Sheila Mikhail
February 9, 2022 02:06 PM ESTUpdated February 10, 11:45 AM
Pharma
Manufacturing

Bay­er-owned AskBio will shift fo­cus to­ward its dog­gy­bone DNA in re­struc­ture with Touch­light

Josh Sullivan

The year was 2018, and AskBio CEO Sheila Mikhail want­ed 100% con­trol­ling in­ter­est in a joint ven­ture with Touch­light. The com­pa­ny was in ne­go­ti­a­tion with …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

Mod­er­na CEO de­fends pan­dem­ic prep ef­forts with crit­ics set to en­ter Trump’s ad­min­is­tra­tion

Trade group tells FDA that semaglu­tide is not too 'com­plex' for com­pound­ing

A service from the Financial Times